Pfizer divests 2 brands to Abbott for 30 crore
On another international track, Pfizer had also agreed to create a global consumer healthcare company with GlaxoSmithKline, following the latter's global decision in December 2018 to separate its pharma business from consumer healthcare PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') PFIZER LTD. - 500680 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Pfizer Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate. Pfizer Ltd - 500680 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') Broker's call: Pfizer (Buy)
Centrum BrokingPfizer (Buy)CMP: 2,765.6Target: 3,320Key takeaways: a) Revenues grew 13 per cent y-o-y: Pfizer's revenues grew 13 per cent y-o-y to Pfizer Ltd - 500680 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed press release for the financial results for the quarter ended December 31, 2018. Please take the above on record. PFIZER LTD. - 500680 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed press release for the financial results for the quarter ended December 31, 2018. Please take the above on record. PFIZER LTD. - 500680 - Unaudited Financial Results For The Quarter Ended December 31, 2018.
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the unaudited financial results for the quarter ended December 31, 2018, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 5:30 p.m. and concluded at 7:30 p.m. Also please find enclosed the Limited Review Report by our Auditors M/s. Walker Chandiok & Co LLP, in respect of the above results. Please take the above on record. PFIZER LTD. - 500680 - Board Meeting Intimation for Board Meeting For The Unaudited Financial Results For The Quarter Ended December 31, 2018 And Intimation Of Closure Of Trading Window.
PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2019 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, January 24, 2019, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter December 31, 2018. Please be informed that the Trading Window for trading in the Equity shares of the Company will be closed from January 15, 2019 to January 26, 2019, both days inclusive. We request you to kindly take the same on record. Pfizer offers severance package to employees of Chennai, Aurangabad units
The package offers statutory bonus, gratuity and a compensation of 15 days' wages for every completed year of service. An early bird incentive of Rs 7 lakh has also been offered